Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.10), $0.18 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $444.33 million versus the consensus estimate of $459.4 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.